Journal article · 2025 · Open access

Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors

Gonna Somu Naidu, Riccardo Rampado, Preeti Sharma, Assaf Ezra, Govinda Reddy Kundoor, Dor Breier, Dan Peer

ACS Nano, 19(6), 6571–6587 · Published 6 February 2025 · DOI 10.1021/acsnano.4c18636

Open full textCite this paper

In brief

“Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors” is a 2025 journal article by Gonna Somu Naidu and 6 co-authors, published in ACS Nano. OpenAlex counts 84 citations as of 21 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at ACS Nano.

Citations
84
Most cited in
2026 (56)
Field-weighted impact
17.04
References
54
Authors
7

Abstract

High Resolution Image Download MS PowerPoint Slide Lipid nanoparticles (LNPs) have emerged as a groundbreaking delivery system for vaccines and therapeutic mRNAs. Ionizable lipids are the most pivotal component of LNPs due to their ability to electrostatically interact with mRNA, allowing its encapsulation while concurrently enabling its endosomal escape following cellular internalization. Thus, extensive research has been performed to optimize the ionizable lipid structure and to develop formulations that are well tolerated and allow efficient targeting of different organs that result in a high and sustained mRNA expression. However, one facet of the ionizable lipids’ structure has been mostly overlooked: the linker segment between the ionizable headgroup and their tails. Here, we screened a rationally designed library of ionizable lipids with different biodegradable linkers. We extensively characterized LNPs formulated using these ionizable lipids and elucidated how these minor structural changes in the ionizable lipids structure radically influenced the LNPs’ biodistribution in vivo. We showed how the use of amide and urea linkers can modulate the LNPs’ p K a, resulting in an improved specificity for lung transfection. Finally, we demonstrated how one of these lipids (lipid 35) that form LNPs entrapping a bacterial toxin [pseudomonas exotoxin A (mmPE)] in the form of an mRNA reduced tumor burden and significantly increased the survival of mice with lung metastasis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Naidu, G. S., Rampado, R., Sharma, P., Ezra, A., Kundoor, G. R., Breier, D., & Peer, D. (2025). Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors. ACS Nano, 19(6), 6571–6587. https://doi.org/10.1021/acsnano.4c18636

MLA 9

Naidu, Gonna Somu, et al. “Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors.” ACS Nano, vol. 19, no. 6, 2025, pp. 6571–6587. https://doi.org/10.1021/acsnano.4c18636.

Chicago

Naidu, Gonna Somu, Riccardo Rampado, Preeti Sharma, Assaf Ezra, Govinda Reddy Kundoor, Dor Breier, and Dan Peer. 2025. “Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors.” ACS Nano 19 (6): 6571–6587. https://doi.org/10.1021/acsnano.4c18636.

Harvard

Naidu, G. S. et al. (2025) ‘Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors’, ACS Nano, 19(6), pp. 6571–6587. doi:10.1021/acsnano.4c18636.

IEEE

G. S. Naidu et al., “Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors,” ACS Nano, vol. 19, no. 6, pp. 6571–6587, 2025, doi: 10.1021/acsnano.4c18636.

BibTeX

@article{naidu2025ionizable,
  title     = {{Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors}},
  author    = {Naidu, Gonna Somu and Rampado, Riccardo and Sharma, Preeti and Ezra, Assaf and Kundoor, Govinda Reddy and Breier, Dor and Peer, Dan},
  journal   = {ACS Nano},
  year      = {2025},
  volume    = {19},
  number    = {6},
  pages     = {6571--6587},
  doi       = {10.1021/acsnano.4c18636},
  url       = {https://doi.org/10.1021/acsnano.4c18636}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • ionizable lipids
  • lipid nanoparticles
  • mRNA delivery
  • linker design
  • amide linker
  • urea linker
  • lung targeting
  • tissue distribution

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Naidu, G. S., Rampado, R., Sharma, P., Ezra, A., Kundoor, G. R., Breier, D., & Peer, D. (2025). Ionizable Lipids with Optimized Linkers Enable Lung-Specific, Lipid Nanoparticle-Mediated mRNA Delivery for Treatment of Metastatic Lung Tumors. ACS Nano, 19(6), 6571–6587. https://doi.org/10.1021/acsnano.4c18636

How many times has this paper been cited?

84 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at ACS Nano: sign in and open the full text from this page.

Who wrote this paper?

Gonna Somu Naidu, Riccardo Rampado, Preeti Sharma, Assaf Ezra, Govinda Reddy Kundoor, Dor Breier, Dan Peer.

What is the DOI of this paper?

10.1021/acsnano.4c18636, permanently at https://doi.org/10.1021/acsnano.4c18636. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.